Remove Health Technology Remove Life Science Remove mHealth
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. The remaining 40% consists of screening and diagnostics, wellness and disease prevention, supply of therapies and digital pharmacies.

article thumbnail

The future of digital healthcare

Waracle

Digital healthcare represents the convergence of technology and life sciences. New technological advancements enable digital healthcare providers to process information and data relative to thousands (and often millions) of patients. The current state of technology in digital healthcare. What is digital healthcare?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 must-know perspectives on digital transformation for healthcare IT leaders

Redox

During this webinar replay, Informatica’s chief strategist of healthcare and life sciences discusses the major trends driving healthcare in 2024. Healthcare and Life Sciences Insights.” Buyer Mindsets: Health Technology Perspectives from Clinical and Clinical IT Leaders.” The Journal of mHealth.

article thumbnail

The The Five Biggest Areas of Opportunity for Digital Health

The Digital Health Corner

Opportunities thus exist for life sciences and technology companies to develop products for this new therapeutic approach. The role of personally derived connected data (from sensors external or internal to the body) will also facilitate personalized medical care. Social Media.

article thumbnail

With Wristband, Google Entering Consumer Health on Its Own Terms

Chilmark Research

The health-tracking wristband is a long-term play. Andrew Conrad, a molecular biologist and head of the life sciences team at Google, told Bloomberg he could see doctors giving the device to all patients – in 20 or 30 years. Very long-term. Over time, though, the limitations of watches and wristbands will continue to manifest.